A translocation that involves chromosome X (band pll.2) and chromosome 18 (band qll.2) was observed in short-term in vitro cultures of cells from five synovial sarcomas and one malignant fibrous histiocytoma. In four of these tumors, the translocation t(X;18)(pll.2;qll.2) was reciprocal. The two other tumors had complex translocations: t(X;18;21)(pll.2;qll.2;p13) and t(X;15;18)(pll.2;q23;qll.2).
The identification of nonrandom chromosomal changes in human leukemias is useful in diagnosis and classification, particularly of the acute leukemias (1) . The alterations also provide clues to the genesis of these neoplasms. Cytogenetic analysis of human solid tumor cells is more complex, and progress has been slow. However, technical advances have yielded the karyotypes of some solid tumors, which can be utilized in analytical investigations of the etiology, diagnosis, and prognosis of these cancers (1) .
Cytogenetic studies of soft tissue sarcomas in humans have remained largely unexplored. To date nonrandom primary changes have been found in two types of soft tissue sarcoma, liposarcomas (2) and certain subtypes of rhabdomyosarcoma (3, 4) . Another soft tissue sarcoma, synovial sarcoma, has been analyzed extensively in the clinical and pathology literature, but its chromosome pattern has been described in only a single report (5) .
Synovial sarcoma, according to the experience of Enzinger and Weiss (6) , is the fourth most common type of soft tissue sarcoma. The neoplasm usually develops in adolescents and young adults, is more common in males than females, and has no racial bias.
A sex chromosome has not been shown to be involved in a consistent primary chromosomal change in any human neoplasm. In a study of the karyotype of soft tissue sarcomas in humans, we detected translocations affecting the X chromosome in four synovial sarcomas. The observation prompted a critical review of two soft tissue sarcomas (one poorly differentiated and one spindle cell) in which we had identified similar changes in the X chromosome (7) . This report describes the findings of a more detailed histological and chromosomal analysis of these six tumors. Patient 4. The patient is a 30-year-old black male who noted a 0.5-cm protuberance in the right proximal thenar eminence in October, 1980. X-rays were negative, and he was observed. The mass continued to enlarge, and an exploration of the right hand in 1981 revealed a tumor invading the thenar musculature and the median nerve. A partial excision was performed, and the diagnosis was a high-grade monophasic synovial sarcoma. The patient subsequently had a right forearm amputation that showed microscopic foci of residual synovial sarcoma. Three years later, he developed pulmonary metastases that were resected and treated with daunomycin and cyclophosphamide. He developed additional pulmonary nodules that have been surgically removed.
MATERIALS AND METHODS
Immunohistochemical study of a pulmonary metastasis revealed the presence of keratin proteins within many of the tumor cells, as is characteristic of synovial sarcoma.
Patient 5. An 18-year-old white male underwent resection of a huge (2.8 kg) calcified retroperitoneal mesenchymal sarcoma in 1979 and received postoperative chemotherapy for a year. However, he required additional surgery for four recurrences in the chest and abdomen during the next 6 years. The patient died of progressive disease in September 1985. Tumors from the primary and several metastatic sites were similar in appearance and were classified initially as poorly differentiated soft tissue sarcoma (7) . Immunohistochemical examination showed strong reactivity of spindle tumor cells for keratin proteins and led to a final diagnosis of monophasic synovial sarcoma.
Patient 6. A 59-year-old white female underwent a resection of a primary tumor of the abdominal wall in February 1984, that arose at a cholecystectomy incision site. Three local recurrences of the tumor were successfully excised in the next 10 months, and the patient has been free of disease during the ensuing 16 months of follow-up.
The primary tumor was initially diagnosed as a low-grade malignant fibrous histiocytoma. The local tumor recurrences were consistent with a spindle cell sarcoma, and this diagnosis was proposed for the primary tumors as well (7). Moreover, no keratin proteins were found on a further immunohistochemical examination of the tumor. The final diagnosis was malignant fibrous histiocytoma.
None of the six patients had a family history of cancer, though the mother of patient 6 died of a carcinoma of the liver.
Immunohistochemical Procedures. Immunoperoxidase studies were performed to detect keratin proteins in the tumors. The presence of keratin proteins in the cytoplasm of tumor cells is a characteristic property of synovial sarcoma and aids in the identification of monophasic synovial sarcoma (8) . The following antibodies were used: a rabbit polyclonal antibody to human callus (Dako, Santa Barbara, CA) at a dilution of 1:100 (8); a rabbit polyclonal antibody to bovine muzzle keratin (Dako) at 1:100 (9); mouse monoclonal antibodies AE1 and AE3 (Boehringer Mannheim) at 1:200 (9); and a mouse monoclonal anticytokeratin antibody (catalog number 7650, Becton Dickinson), following instructions in the supplier's kit.
Chromosomal Analysis. G-banded metaphases were obtained from short-term cultures of cell suspensions after collagenase disaggregation of surgical specimens from patients 1 and 3-6 according to a procedure described (10) . In patient 2, xenografted tumors were generated in nude mice from a primary tumor specimen. The material from passage 2 was used for cytogenetic studies. The specimen was short-term cultured after its disaggregation with collagenase.
The dates on which the specimens were obtained and the origin of the specimens are presented in Table 1 (Fig. 1) . The reciprocal exchanges between the different chromosomes are schematically presented in Fig. 2 . The chromosome patterns resulting from the complex translocation t(X;18;21) in patient 2 allowed the breakpoints to be assigned clearly at Xpll.2 and 18q11.2 (Fig. 2B) . These clear-cut locations substantiated the assignment of the breakpoints in the simple translocations (patients 1, 2, 3, 4 , and 5; A, B, C, D, and E, respectively) and one patient with malignant fibrous histiocytoma (patient 6; F). An X chromosome is involved in simple reciprocal translocations with chromosome 18 (derl8) in patients 1, 4, 5, and 6 (A, D, E, and F, respectively). An X chromosome is involved in complex translocations with chromosome 21 (der2l) in addition to chromosome 18 in patient 2 (B) and with chromosome 15 (dernS) in addition to chromosome 18 in patient 3 (C).
was not detected in the constitutional karyotype of three of our patients. Confirmation of the breakpoints can be obtained by the use of molecular probes mapped to the involved regions of Xp and 18q.
The change involving the X chromosome was observed in five patients with synovial sarcoma and in one patient with malignant fibrous histiocytoma. The change was found in both major types of synovial sarcoma, i.e., in the classical biphasic type (patient 1) and in the monophasic spindle cell type (patients 2-5). In the four patients of monophasic synovial sarcoma, the diagnosis was suggested by histologic examination and was confirmed in each by the immunohistochemical demonstration ofkeratin proteins in the malignant tumor cells as is characteristic of these tumors (12) . No keratin proteins were demonstrable in the malignant fibrous histiocytoma (patient 6), as reported (8) .
In the literature, the only cytogenetic study on a synovial sarcoma showed a deletion of chromosome 1 and a translocation between the long arms of chromosomes 2 and 9, but no changes involving chromosomes X and 18 (5) . Studies of other soft tissue sarcomas have also not shown clonal abnormalities of chromosomes X and 18. Nonrandom involvement of chromosomes 2, 3, and 13 has been found in rhabdomyosarcoma (3, 4) and chromosomes 12 and 16 in myxoid liposarcoma (2) .
The translocation involving Xpll.2 and 18q11.2 appears to characterize at least five synovial sarcomas in unrelated patients and to constitute a tumor-related (primary) chromosome change. To our knowledge, this is the first example of a nonrandom change involving a sex chromosome in a specific form of cancer. In the remaining patient (patient 6) in our series, the diagnosis was another form of soft tissue sarcoma, a malignant fibrous histiocytoma. Disagreement and errors in subclassification of soft tissue sarcoma are common and were found in one-third of the 216 patients in a histopathology review (12) .
Immunohistochemical studies can improve diagnostic accuracy. Patient 6 showed no keratin proteins to support the diagnosis of a synovial sarcoma, but only a small specimen was available for study. Nevertheless this case raises the possibility that a few tumors not classified as synovial sarcomas by conventional criteria may also bear a t(X;18) rearrangement.
Clonal translocations involving the X chromosome have been tabulated in a wide variety of human solid tumors (7) . Though the breakpoints on the X chromosome of these tumors clustered preferentially in bands Xp22, Xq22, and Xq28, the translocated fragments of the X chromosome were rearranged to diverse autosomes without consistent patterns. In addition, the chromosome changes in these tumors showed no correlation with histology or site of the primary tumor.
Detection of the X;18 translocation in additional synovial sarcomas, but not in other tumors, can help establish the finding as a diagnostic tool. The observation may also be useful because the diagnosis of synovial sarcoma is difficult in some cases, with poorly differentiated histology.
Until recently none of the known and expressed oncogenes had been mapped to the human X chromosome (13) , and it has been suggested that the mammalian X chromosome was deprived of oncogenes and related genes by a process of evolutionary preadaptation (14) . However, a gene in the RAF oncogene group, ARAFI, has now been mapped to the human X chromosome between Xp21 and Xqll (15), a region that encompasses the breakpoint on chromosome X in synovial sarcoma. Whether this very newly described oncogene, which is actively transcribed in human T cells, fetal liver cells, and HL-60 cells (15) , plays a role in the pathogenesis of synovial sarcoma merits study. No oncogene has been mapped to the other consistent breakpoint in synovial sarcoma, 18qll.2. However, the YES] oncogene and the (17) . Another gene possibly involved in the development of synovial sarcoma is the erythroid-potentiating activity/tissue-inhibitor of metalloproteinase gene (EPA/TIMP gene), which also has been mapped to Xpl1.1-Xpll.4 (18) . The tissue inhibitor of metalloproteinase (TIMP) is an inhibitor of collagenase and other tissue metalloproteinases and has been purified from pig synovium among other sources (19) . The physiological properties and regulation of this gene are still poorly understood. As in the case of ARAFI, the role of the EPA/TIMP gene in synovial sarcoma is yet to be established.
